Insiders Sold These Healthcare Shares Last Week

Wall St. Watchdog reveals information about insiders who are bearish on these stocks in the Healthcare sector for the week ending November 4th, 2011.

  • Stephen J Cosgrove who is Corporate Controller at Johnson & Johnson (NYSE:JNJ), sold 26,300 shares on Oct 28 at $65.45 per share for a total value of $1,721,335. The shares recently traded at $64.00, down $1.6, or 2.44% since the insider sale. About the company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world. Get the most recent company news and stock data here >>
  • David S Wichmann who is EVP & CFO, Pres UHG Operations at Unitedhealth Group, Inc. (NYSE:UNH), sold 300,000 shares on Oct 28 at $48.88 per share for a total value of $14,663,520. The shares recently traded at $45.17, down $3.68, or 7.53% since the insider sale. About the company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers. Get the most recent company news and stock data here >>
  • Ronda E Stryker who is Director at Stryker Corp. (NYSE:SYK), sold 9,000 shares on Oct 28 at $49.68 per share for a total value of $447,152. The shares recently traded at $49.06, down $0.86, or 1.72% since the insider sale. About the company: Stryker Corporation develops, manufactures, and markets specialty surgical and medical products. The Company’s products include implants, biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. Get the most recent company news and stock data here >>
  • James M Cornelius who is Director at Bristol-Myers Squibb Company (NYSE:BMY), sold 440,188 shares on Oct 31 at $31.87 per share for a total value of $14,029,804. The shares recently traded at $31.39, down $0.2, or 0.63% since the insider sale. About the company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Get the most recent company news and stock data here >>
  • Jenne K Britell who is Director at Quest Diagnostics Inc. (NYSE:DGX), sold 7,500 shares on Nov 03 at $55.70 per share for a total value of $417,750. The shares recently traded at $56.83, up $1.24, or 2.23% since the insider sale. About the company: Quest Diagnostics Incorporated provides diagnostic testing, information, and services. The Company operates a national network of full-service laboratories, rapid response laboratories, and patient service centers. Quest Diagnostics provides esoteric testing, routine medical testing, drugs of abuse testing, and non-hospital-based anatomicpathology testing. Get the most recent company news and stock data here >>
  • Russell C Deyo who is VP, General Counsel at Johnson & Johnson (NYSE:JNJ), sold 123,300 shares on Nov 03 at $64.09 per share for a total value of $7,902,297. The shares recently traded at $64.00, down $0.34, or 0.53% since the insider sale. About the company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from publicly available SEC filings. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>